Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Non-Current Assets: 2014-2024

Historic Non-Current Assets for KalVista Pharmaceuticals (KALV) over the last 8 years, with Apr 2024 value amounting to $9.7 million.

  • KalVista Pharmaceuticals' Non-Current Assets was N/A to $8.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $8.8 million, marking a year-over-year change of. This contributed to the annual value of $9.7 million for FY2024, which is N/A change from last year.
  • KalVista Pharmaceuticals' Non-Current Assets amounted to $9.7 million in FY2024, which was up 153.43% from $3.8 million recorded in FY2020.
  • In the past 5 years, KalVista Pharmaceuticals' Non-Current Assets ranged from a high of $9.7 million in FY2024 and a low of $3.8 million during FY2020.
  • Moreover, its 1-year median value for Non-Current Assets was $9.7 million (2024), whereas its average is $9.7 million.
  • Data for KalVista Pharmaceuticals' Non-Current Assets shows a peak YoY spiked of 48.22% (in 2020) over the last 5 years.
  • Yearly analysis of 2 years shows KalVista Pharmaceuticals' Non-Current Assets stood at $3.8 million in 2020, then followed by $9.7 million in 2024.